Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks

Editorial

S C Afford et al. Hepatology. 2001 Jul.

. 2001 Jul;34(1):207-9.

doi: 10.1053/jhep.2001.26212.

No abstract available

Comment on

Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
Schmitz V, Barajas M, Wang L, Peng D, Duarte M, Prieto J, Qian C. Schmitz V, et al. Hepatology. 2001 Jul;34(1):72-81. doi: 10.1053/jhep.2001.25757. Hepatology. 2001. PMID: 11431736

[Current status of immuno-gene therapy for hepatocellular carcinoma].
Ye S. Ye S. Zhonghua Gan Zang Bing Za Zhi. 2002 Dec;10(6):407-8. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12502436 Chinese. No abstract available.
Molecular biological diagnosis and gene therapy of hepatocellular carcinoma: the present status.
Ji JF. Ji JF. Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):724-5. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12914006 No abstract available.
[The application of gene chip in the diagnosis and treatment of hepatocellular carcinoma].
Huang W, Yang DH. Huang W, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 May;12(5):317-8. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15161524 Review. Chinese. No abstract available.
Growing role of CD40 ligand gene transfer therapy in the management of systemic malignancies besides hepatocellular carcinomas.
Kapoor S. Kapoor S. J Zhejiang Univ Sci B. 2009 Mar;10(3):242. doi: 10.1631/jzus.B0950001. J Zhejiang Univ Sci B. 2009. PMID: 19283881 Free PMC article. No abstract available.
Gene therapy strategies for hepatocellular carcinoma.
Hwang LH. Hwang LH. J Biomed Sci. 2006 Jul;13(4):453-68. doi: 10.1007/s11373-006-9085-7. Epub 2006 Apr 22. J Biomed Sci. 2006. PMID: 16633742 Review.

High promoter activity of cytokeratin-19 gene in cholangiocarcinoma.
Qin J, Wang M, Qin J, Cai Q, Peng ZH. Qin J, et al. Mol Clin Oncol. 2018 Oct;9(4):467-471. doi: 10.3892/mco.2018.1700. Epub 2018 Aug 16. Mol Clin Oncol. 2018. PMID: 30233800 Free PMC article.